Company: MIRA
Filing Date: 2025-06-17
Form Type: PREM14A
Source: 0001641172-25-015340
Chunk: 8

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: PREM14A
Chunk 8
---
 each of the following proposals:

| 1. | the                                                                                                                              
 approval of the issuance of shares of MIRA Common Stock or other securities of MIRA pursuant to the Merger, which will represent 
 (or are convertible into) more than 20% of the shares of MIRA Common Stock outstanding immediately prior to the Merger, pursuant 
 to Nasdaq Listing Rule 5635(a) (the “Merger Proposal” or “Proposal No. 1”); and                                                  |

| 1 |

| 2. | the                                                                                                                                 
 approval of a postponement or adjournment of the MIRA virtual special meeting, if necessary, to solicit additional proxies if there 
 are not sufficient votes in favor of Proposal No. 1 (the “Adjournment Proposal” or “Proposal No. 2”).                               |

We do not expect that any matter other than Proposal Nos. 1 and 2 will be brought before the MIRA virtual special meeting.

Q: What is required to consummate the Merger?

A:To consummate the Merger, the holders of MIRA Common Stock must approve the Merger Proposal. Proposal No. 2 is not a closing condition for the consummation of the Merger.

In addition to the requirement of obtaining stockholder approval of the Merger Proposal, each of the other closing conditions set forth in the Merger Agreement must be satisfied or, unless not waivable as a matter of law, waived. For a complete description of the closing conditions under the Merger Agreement, we urge you to read the section titled “ The Merger Agreement—Conditions to the Merger.”

Q: How can I find out the results of the voting at the MIRA virtual special meeting?

A:Final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the MIRA virtual special meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the MIRA virtual special meeting, we intend to file a Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results.

Q: Will holders of the MIRA Common Stock issued in the Merger be able to sell those shares without restriction?

A:The shares of MIRA Common Stock issued as consideration in the Merger will be issued in transactions exempt from registration under the Securities Act of 1933